EBV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR THE TREATMENT OF LOCOREGIONAL NASOPHARYNGEAL CARCINOMA (NPC)

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP11822672.9

公开号：

EP2611905A1

申请日:

2011.09.01

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

The present invention concerns methods and compositions for treatment of locoregional nasopharyngeal carcinoma utilizing EBV-specific T cells. In specific embodiments, locoregional solid tumors are treated with cytotoxic T lymphocytes specific for at least one EBV antigen, such as LMP2, LMP1, and/or EBNA1, for example.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/